• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Comparative genetic analysis of central nervous system lymphomas between sites in the central nervous system or extracranial organs

Research Project

Project/Area Number 18K08950
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 56010:Neurosurgery-related
Research InstitutionKyorin University

Principal Investigator

Kobayashi Keiichi  杏林大学, 医学部, 学内講師 (70406990)

Co-Investigator(Kenkyū-buntansha) 市村 幸一  国立研究開発法人国立がん研究センター, 研究所, 分野長 (40231146)
永根 基雄  杏林大学, 医学部, 教授 (60327468)
Project Period (FY) 2018-04-01 – 2021-03-31
Project Status Completed (Fiscal Year 2020)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2019: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2018: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Keywords中枢神経系悪性リンパ腫 / 二次性中枢神経系悪性リンパ腫 / 遺伝子変異解析 / メチル化アレイ / 二次性悪性リンパ腫 / 脳腫瘍 / 分子遺伝子学
Outline of Final Research Achievements

In order to search for mutations of central nervous system (CNS) lymphomas which might serve as driver mutations in the CNS, we have performed targeted sequencing in paired samples from four secondary central nervous system lymphoma (SCNSL) cases and two systemic relapse of primary central nervous system (PCNSL) cases. Mutational profiles were compared between the primary and recurrent tumor. MYD88, CD79B and PIM1 mutations were observed as shared mutations in all cases, therefore seemed to be relatively early genetic events. In the SCNSL cases, several de novo mutations were enriched only among the recurrent CNS tumors. One of those mutations were observed in 3/4 (75%) cases, and two mutations were observed in 2/4 (50%) cases. It is suggested that these de novo mutations in the recurrent CNS tumors might serve as driver mutations in the CNS. Further analysis in larger cohorts, and functional studies are required in order to validate these findings.

Academic Significance and Societal Importance of the Research Achievements

PCNSL全身性再発、SCNSLに関する遺伝学的解析はその希少性から、特にPCNSL全身性再発、SCNSLの両者を解析し比較検討した報告は少ない。今回複数の遺伝子異常がDLBCLの中枢神経系病変に特徴的であることが示唆されたことはPCNSL、SCNSLの病態解明に寄与するとともに、予後不良であるこれらの疾患における治療標的としての検討につながる社会的意義がある。

Report

(4 results)
  • 2020 Annual Research Report   Final Research Report ( PDF )
  • 2019 Research-status Report
  • 2018 Research-status Report
  • Research Products

    (16 results)

All 2021 2020 2018

All Journal Article (6 results) (of which Int'l Joint Research: 2 results,  Peer Reviewed: 3 results,  Open Access: 2 results) Presentation (8 results) (of which Int'l Joint Research: 4 results,  Invited: 3 results) Book (2 results)

  • [Journal Article] 中枢神経系原発悪性リンパ腫2021

    • Author(s)
      永根基雄
    • Journal Title

      日本臨牀

      Volume: 79 Pages: 207-212

    • Related Report
      2020 Annual Research Report
  • [Journal Article] Phase I/II study of tirabrutinib, a second-generation Bruton's tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma2021

    • Author(s)
      Narita Y, Nagane M, Mishima K, Terui Y, Arakawa Y, Yonezawa H, Asai K, Fukuhara N, Sugiyama K, Shinojima N, Kitagawa J, Aoi A, Nishikawa R.
    • Journal Title

      Neuro Oncol

      Volume: 23 Issue: 1 Pages: 122-133

    • DOI

      10.1093/neuonc/noaa145

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] 中枢神経系原発びまん性大細胞型B細胞リンパ腫2020

    • Author(s)
      永根基雄
    • Journal Title

      血液内科

      Volume: 80 Pages: 623-635

    • Related Report
      2020 Annual Research Report
  • [Journal Article] A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma2020

    • Author(s)
      Tateishi Kensuke、Miyake Yohei、Kawazu Masahito、Sasaki Nobuyoshi、Nakamura Taishi、Sasame Jo、Yoshii Yukie、Ueno Toshihide、Miyake Akio、Matsushita Yuko、Shiba Norio、Udaka Naoko、Ohki Kentaro、Fink Alexandria L.、Tummala Shilpa S.、Natsumeda Manabu、Miller Julie J.、Fujii Yukihiko、et al
    • Journal Title

      Cancer Research

      Volume: 80 Issue: 23 Pages: 5330-5343

    • DOI

      10.1158/0008-5472.can-20-2425

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Consecutive single-institution case series of primary central nervous system lymphoma treated by R-MPV or high-dose methotrexate monotherapy2020

    • Author(s)
      Sasaki N, Kobayashi K, Saito K, Shimizu S, Suzuki K, Lee J, Yamagishi Y, Shibahara J, Takayama N, Shiokawa Y, Nagane M
    • Journal Title

      Jpn J Clin Oncol

      Volume: inpress Issue: 9 Pages: 1-11

    • DOI

      10.1093/jjco/hyaa073

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed
  • [Journal Article] 中枢神経系悪性リンパ腫の治療開発-多剤併用薬物療法及び新規分子標的治療薬2018

    • Author(s)
      永根基雄
    • Journal Title

      最新医学

      Volume: 73 Pages: 1441-1449

    • Related Report
      2018 Research-status Report
  • [Presentation] Molecular pathogenesis and treatment of primary central nervous system lymphoma: Evidence and perspectives2020

    • Author(s)
      Nagane M
    • Organizer
      The 19th International Symposium on Pediatric Neuro-Oncology
    • Related Report
      2020 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] JCOG1114C randomized phase III trial for newly-diagnosed PCNSL comparing HD-MTX + WBRT vs. HD-MTX + WBRT/TMZ followed by adjuvant TMZ2020

    • Author(s)
      Nagane M, Fukumura K, Ueno T, Lee J, Shishido-Hara Y, Mishima K, Ichimura K, Mukasa A, Narita Y, Aburatani H, Nishikawa R, Mano H
    • Organizer
      2020 International PCNSL Collaborative Group Virtual Meeting
    • Related Report
      2020 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Update of the ONO4059-02 study, tirabrutinib monotherapy for r/rPCNSL in Japan2020

    • Author(s)
      Nagane M
    • Organizer
      2020 International PCNSL Collaborative Group Virtual Meeting
    • Related Report
      2020 Annual Research Report
    • Int'l Joint Research
  • [Presentation] 再発中枢神経系原発悪性リンパ腫に対する薬物療法の治療成績と展望2020

    • Author(s)
      永根基雄、佐々木重嘉、小林啓一、齊藤邦昭、島田大輔、松本淑恵、飯島昌平、山岸夢希、清水早紀、佐々木佑太、塩川芳昭
    • Organizer
      第38回日本脳腫瘍学会学術集会
    • Related Report
      2020 Annual Research Report
  • [Presentation] Combined rituximab, methotrexate, procarbazine, vincristine, and cytarabine (R-MPV-A) treatment for patients with relapsed primary CNS lymphoma2020

    • Author(s)
      Motoo Nagane, Nobuyoshi Sasaki, Keiichi Kobayashi, Kuniaki Saito, Daisuke Shimada, Yoshie Matsumoto, Shohei Iijima, Yuki Yamagishi, Saki Shimizu, Yuta Sasaki, Nobuyuki Takayama, Yoshiaki Shiokawa
    • Organizer
      25th Annual Meeting of the Society for Neuro-Oncology
    • Related Report
      2020 Annual Research Report
    • Int'l Joint Research
  • [Presentation] 中枢神経系原発悪性リンパ腫の病態と治療―エビデンスと今後の展望―2020

    • Author(s)
      永根基雄
    • Organizer
      第82回日本血液学会学術集会
    • Related Report
      2020 Annual Research Report
    • Invited
  • [Presentation] 再発中枢神経系原発悪性リンパ腫に対するRMPVA療法の治療成績と展望2020

    • Author(s)
      永根基雄、佐々木重嘉、小林啓一、齊藤邦昭、島田大輔、松本淑恵、飯島昌平、山岸夢希、清水早紀、佐々木佑太、塩川芳昭
    • Organizer
      日本脳神経外科学会 第79回 学術集会
    • Related Report
      2020 Annual Research Report
  • [Presentation] Therapeutic development for malignant brain tumors: past and future perspectives2018

    • Author(s)
      Motoo Nagane
    • Organizer
      The 36th Annual Meeting of the Japan Society of Brain Tumor Pathology
    • Related Report
      2018 Research-status Report
    • Invited
  • [Book] 脳神経外科学II [改訂13版]2020

    • Author(s)
      永根基雄:日本脳腫瘍学会(編)
    • Total Pages
      2770
    • Publisher
      金芳堂
    • ISBN
      9784765318655
    • Related Report
      2020 Annual Research Report
  • [Book] 悪性リンパ腫治療マニュアル(改訂第5版)2020

    • Author(s)
      永根基雄;田村晃,松谷雅生,清水輝夫,辻貞俊,塩川芳昭,成田善孝(編)
    • Total Pages
      395
    • Publisher
      南江堂
    • ISBN
      9784524226450
    • Related Report
      2020 Annual Research Report

URL: 

Published: 2018-04-23   Modified: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi